SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549-1004

 

 

 

 

 

 

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

Date of Report (date of earliest event reported): March 8, 2002

 

 

 

CIPHERGEN BIOSYSTEMS, INC.

(Exact name of Registrant as specified in its charter)

 

 

 

 

Delaware

 

000-31617

 

33-059-5156

(State or other jurisdiction of

 incorporation or organization)

 

(Commission File No.)

 

(I.R.S.  Employer

 Identification Number)

 

 

 

 

6611 Dumbarton Circle

Fremont, CA 94555

(Address of principal executive offices)

 

(510) 505-2100

(Registrant’s telephone number, including area code)

 

 

 



 

ITEM 5.  OTHER EVENTS

On March 8, 2002, Ciphergen Biosystems, Inc. issued a press release announcing that the Board of Directors of Ciphergen approved the adoption of a Stockholder Rights Plan.  The press release is attached as Exhibit 99.3 to this Form 8-K.

ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS

(c)                                  Exhibits.

Exhibit 99.3            Ciphergen Biosystems, Inc. Press Release issued March 8, 2002.

 

 

 

 

 

 

 

 



 

 

SIGNATURE

                Pursuant to the requirements of the Securities Exchange Act or 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

Ciphergen Biosystems, Inc.

(Registrant)

 

 

 

Date:  March 8, 2002

 

 

 

By

/s/ Matthew J. Hogan

 

 

Matthew J. Hogan

 

 

Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 



 

EXHIBIT INDEX

 

Exhibit

 

 

Number

 

 

 

 

 

99.3

 

Ciphergen Biosystems, Inc. Press Release issued March 8, 2002.